Goserelin D10
| Product Name | Goserelin D10 |
|---|---|
| Alternate Names | Goserelin Stable Isotopes, Stable Isotopes of Goserelin |
| CAT No. | CS-O-03216 |
| CAS No. | 65807-02-5(Unlabeled) |
| Category | Stable Isotopes |
| Stock | IN-Stock |
| Mol. Wt. | 1279.47 g/mol |
| Mol. For. | C59H74D10N18O14 |
| Hazardous | This is not a Hazardous Compound |
| COA | View Sample COA |
| MSDS | View Sample MSDS |
| Parent API | Goserelin |
| Purity | 98.03 |
| Therapeutic | Anti-Cancer / Oncology |
| Smileys | O=C(N[C@@H](CO)C(N[C@H](C(N[C@H](COC(C)(C)C)C(NC(C([2H])([2H])C([2H])(C([2H])([2H])[2H])C([2H])([2H])[2H])([2H])C(N[C@@H](CCCNC(N)=N)C(N(CCC1)[C@@H]1C(NNC(N)=O)=O)=O)=O)=O)=O)CC2=CC=C(O)C=C2)=O)[C@@H](NC([C@@H](NC([C@@H](N3)CCC3=O)=O)CC4=CNC=N4)=O)CC5=CNC匀䰀开匀攀氀昀开匀椀最 |
| Canonical Smiles | CC(C)CC(C(=O)NC(CCCN=C(N)N)C(=O)N1CCCC1C(=O)NNC(=O)N)NC(=O)C(COC(C)(C)C)NC(=O)C(CC2=CC=C(C=C2)O)NC(=O)C(CO)NC(=O)C(CC3=CNC4=CC=CC=C43)NC(=O)C(CC5=CN=CN5)NC(=O)C6CCC(=O)N6 |
| InchIKey | BLCLNMBMMGCOAS-URPVMXJPSA-N |
| Inchl | InChI=1S/C59H84N18O14/c1-31(2)22-40(49(82)68-39(12-8-20-64-57(60)61)56(89)77-21-9-13-46(77)55(88)75-76-58(62)90)69-54(87)45(29-91-59(3,4)5)74-50(83)41(23-32-14-16-35(79)17-15-32)70-53(86)44(28-78)73-51(84)42(24-33-26-65-37-11-7-6-10-36(33)37)71-52(85)43(25-34-27-63-30-66-34)72-48(81)38-18-19-47(80)67-38/h6-7,10-11,14-17,26-27,30-31,38-46,65,78-79H,8-9,12-13,18-25,28-29H2,1-5H3,(H,63,66)(H,67,80)(H,68,82)(H,69,87)(H,70,86)(H,71,85)(H,72,81)(H,73,84)(H,74,83)(H,75,88)(H4,60,61,64)(H3,62,76,90)/t38-,39-,40-,41-,42-,43-,44-,45+,46-/m0/s1 |
| IUPAC | (2S)-N-[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2R)-1-[[(2S)-1-[[(2S)-1-[(2S)-2-[(carbamoylamino)carbamoyl]pyrrolidin-1-yl]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-3-[(2-methylpropan-2-yl)oxy]-1-oxopropan-2-yl]amino]-3-(4-hydroxyphenyl)-1-oxopropan-2-yl]amino]-3-hydroxy-1-oxopropan-2-yl]amino]-3-(1H-indol-3-yl)-1-oxopropan-2-yl]amino]-3-(1H-imidazol-5-yl)-1-oxopropan-2-yl]-5-oxopyrrolidine-2-carboxamide |
| Controlled | No |
| Shipping | Free for purchase above 1000$ |
| Delivery | In-Stock, products will be dispatched within 24 hours via FedEx for USA, Europe, and other countries. |
| Return | Returns/replacement accepted if you are not satisfied with the quality of the product, (please send us an email with the reason/issues which are facing, within 15 days, after receipt of the product). |
| Ordering | Place your order online or by email sales@clearsynth.com |
Goserelin D10 is a synthetic hormone that is used in the treatment of various medical conditions. It is a modified version of the natural hormone gonadotropin-releasing hormone (GnRH) and is sold under the brand name Zoladex. Goserelin D10 works by suppressing the production of certain hormones in the body which can be useful in treating conditions like prostate cancer, breast cancer, and endometriosis.
Goserelin D10 is administered through an injection under the skin every 28 days. The dosage and duration of treatment depend on the specific medical condition being treated, and it is important to follow the instructions of the healthcare provider. The injection should be given at the same time every month to ensure the best results.
The chemical structure of Goserelin D10 consists of a peptide chain of 10 deuterium-labeled amino acids. It has a molecular weight of approximately 1329.6 g/mol. The chemical formula for Goserelin D10 is C59H84N18O14 and its CAS number is 69278-18-8.
Goserelin D10 is a potent hormone and should be used with caution. Side effects may include hot flashes, headaches, mood changes, and decreased sex drive. In rare cases, it may cause serious allergic reactions. It is important to inform the healthcare provider of any medical conditions or medications being taken before starting treatment with Goserelin D10.
Get an Instant Quote
Related Compounds
Goserelin-d7 | Goserelin-D7 Tris Trifluoroacetate |